Table 1.
Key characteristics of people with CF diagnosed with SARS-CoV-2 before 13th June 2020, by transplant status.
| Overall | Non- transplant | Post-transplant | |
|---|---|---|---|
| N = 181 | N = 149 | N = 32 | |
| Sex; n (%1) | |||
| Female; | 90 (50) | 78 (52) | 12 (38) |
| Male; | 91 (50) | 71 (48) | 20 (63) |
| Age; median (range) | 27 (0–74) | 24 (0–74) | 38 (9–50) |
| Age; n(%1) | |||
| <18 | 53 (29) | 51 (34) | 2 (6) |
| 18–39 | 92 (51) | 75 (50) | 17 (53) |
| ≥40 | 36 (20) | 23 (15) | 13 (41) |
| Genotypes; n (%1) | |||
| Homozygous F508del | 72 (40) | 53 (36) | 19 (59) |
| Heterozygous F508del | 65 (36) | 55 (37) | 10 (31) |
| Other | 42 (23) | 40 (27) | 2 (6) |
| CFRD; n (%1) | |||
| No | 90 (50) | 83 (56) | 7 (22) |
| Yes | 56 (31) | 36 (24) | 20 (63) |
| Missing2 | 35 (19) | 30 (20) | 5 (16) |
| Pseudomonas; n (%1) | |||
| No | 80 (44) | 68 (46) | 12 (38) |
| Yes | 92 (51) | 76 (51) | 16 (50) |
| Missing2 | 9 (5) | 5 (3) | 4 (13) |
| Best FEV1; median (range) | 76 (18–123) | 73 (18–123) | 80 (19–114) |
| Best FEV1; n (%1) | |||
| <40 | 24 (13) | 23 (15) | 1 (3) |
| 40–70 | 47 (26) | 39 (26) | 8 (25) |
| >70 | 89 (49) | 73 (49) | 16 (50) |
| Missing2 | 21 (12) | 14 (9) | 7 (22) |
| BMI; median (range) | 21 (13–38) | 21 (13–38) | 21 (16–29) |
| Missing2; n (%1) | 29 (16) | 28 (19) | 1 (3) |
Where no 'Missing' row is included, variables are 100% complete.
1
Column proportions are calculated (n/N) for each descriptive category from the column total of each cohort.
2
Proportions of missing data are calculated from the column total of each cohort.